June 12, 2020, is International NASH Day and Wayne Eskridge, cirrhosis patient and founder of the Fatty Liver Foundation and Donna Cryer, liver transplant patient and the president and CEO of the Global Liver Institute discuss non-alcoholic steatohepatitis (NASH) and concerns surrounding NASH during COVID-19.
Wayne Eskridge, Fatty Liver Foundation President and CEO. Wayne Eskridge, an electrical engineering graduate from the University of Idaho, worked in software and electronics through a 50-year professional career. He served in many technical and managerial roles beginning as a computer programmer, through multiple levels of technical and managerial positions in businesses of all sizes. He held executive positions in both public and private corporations with worldwide responsibilities, and from startups to Fortune 500 firms. In 2015 Wayne was diagnosed with stage 4 NASH with cirrhosis. He had no symptoms and didn’t know that his diet, typical of so many Americans, was unhealthy and damaging to his liver. As a result of his own experiences, he became aware of an acute need for educational resources for patients. While there is currently no medical treatment for NAFLD/NASH, lifestyle changes can be effective. Wayne believes that prevention through education is the only practical solution today. His desire to help others avoid his experiences led him to the decision to become a patient champion and to create the Fatty Liver Foundation.